Audit Compensation Nominating and Corporate Governance
Larry Ellberger Chairman of the Board Financial Expert Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Herbert J. Conrad   Member of Compensation Committee Member of Nominating and Corporate Governance Committee
George O. Elston Financial Expert Committee Chair for Audit Committee    
James J. Marino,, J.D.   Committee Chair for Compensation Committee  
Former Partner, Dechert LLP

Mr. Marino has been a director of Celldex since March 2017. He was with the global law firm of Dechert LLP for 28 years, where he served as Managing Partner of the Princeton, N.J. office. His practice focused on the representation of leading life sciences companies, both privately- and publicly-held, in a broad range of corporate, transactional and finance matters. Mr. Marino currently serves on the Board of Trustees of Wake Forest University and Wake Forest University Baptist Medical Center and on the Board of Directors of Onconova Therapeutics, Inc. He previously served on the Board of Directors of Pharmacopeia, Inc. He has also worked in advisory capacities and on the boards of multiple non-profit organizations, including Robert Wood Johnson University Hospital. Additionally, Mr. Marino is a co-founder of BioNJ, the trade association of biotechnology companies based in New Jersey, which he represented from its inception. Mr. Marino received his B.A., his M.B.A. and his J.D. from Rutgers University.


Harry H. Penner, Jr., J.D., L.L.M. Member of Audit Committee Member of Compensation Committee  
Karen L. Shoos, J.D.     Committee Chair for Nominating and Corporate Governance Committee
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member Financial Expert = Financial Expert
Chair of the Board = Chair of the Board
Committee Chair = Chair
Committee Member = Member
Financial Expert = Financial Expert

Stock transaction information provided by EDGAR Online. Celldex Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.